NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, France, Japan, Greater China, and internationally. Its TTFields devices include...
11 insider purchases on record · latest filing 2025-09-08.
Insiders have also filed 897 sale transactions at NVCR.